Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
STAR: Glucocorticoid Withdrawal Strategies in RA
NCT02997605Phase 4Completed
- Sponsor
- Centre hospitalier universitaire de Toulouse
- Start
- Jan 2017
- Primary completion
- Jan 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of hydrocortisone in rheumatoid arthritis (RA), sponsored by Centre hospitalier universitaire de Toulouse. Started Jan 2017; status: completed.
02
Drugs
hydrocortisone
03
Conditions
rheumatoid arthritis (RA)
Beyond the preview
Go deeper on NCT02997605.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02997605.